Watch CUE. Know when insiders buy.
One email the day a filing lands. Free.
CUE
Cue Biopharma, Inc.
18.43
−0.23 −1.23%
USD · close Oct 26
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
46
WATCH · insiders 34, shorts 57
Insiders, 90 days
−$389K
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $133.9MP/E —DIV YIELD —FCF YIELD -37.47%REV TTM $37.7M +354.4%NET INCOME −$164.1MNET CASH $16.4M52W 5.31 – 37.84SEC XBRL · TTM TO Invalid Date
Insider trading
−$389K
Net, 90 days
0 / 4
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 12 | Oct 14 | Meluzio Michael Vincent · VP, Prin. Accounting Officer | Sell | 1,144 | $28.05 | $32K |
| Oct 12 | Oct 14 | Lin Shao-Lee · Chief Executive Officer | Sell | 1,087 | $28.05 | $30K |
| Oct 12 | Oct 14 | Lin Shao-Lee · Chief Executive Officer | Sell | 10,000 | $27.50 | $275K |
| Oct 12 | Oct 14 | Ray Sumita · Chief Legal Compliance Officer | Sell | 1,844 | $28.05 | $52K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.